A. Kwong, J.D. Firth, T.J. Farmer et al.
Tetrahedron 81 (2021) 131899
4.4. General procedure C: lithiation-trapping in THF or 2-MeTHF
followed by incubation
4.7. 2-Trimethylsilyl pyrrolidine-1-carboxylic acid tert-butyl ester 3
Using general procedure A, s-BuLi (2.0 mL of a 2.6 M solution in
s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol) was
added dropwise to a stirred solution of N-Boc pyrrolidine 1 (171 mg,
hexanes, 2.6 mmol) and N-Boc pyrrolidine 1 (342 mg, 350 mL,
2.0 mmol) in 2-MeTHF (10 mL) at ꢀ20 ꢁC for 2 min and Me3SiCl
175
m
L,1.0 mmol) in THF or 2-MeTHF (7 mL) at ꢀ30 ꢁC under Ar. The
(326 mg, 381 mL, 3.0 mmol) gave the crude product. Purification by
resulting solution was stirred at ꢀ30 ꢁC for 5 min. The reaction flask
flash column chromatography on silica with 8:2 petrol-Et2O as
eluent gave silyl pyrrolidine 3 (254 mg, 52%) as a colourless oil, RF
was transferred to a 0 ꢁC bath and stirred at 0 ꢁC for 5 or 30 min.
Then, Me3SiCl (218 mg, 256
mL, 2.0 mmol) was added. The resulting
(8:2 petrol-Et2O) 0.4; 1H NMR (400 MHz, CDCl3)
d 3.56-3.41 (m, 1H,
solution was stirred at 0 ꢁC for 10 min and then allowed to warm to
rt over 1 h. Saturated NH4Cl(aq) (10 mL) was added and the two
layers were separated. The aqueous layer was extracted with Et2O
(3 ꢄ 10 mL) and the combined organic layers were dried (MgSO4)
and evaporated under reduced pressure to give the crude product.
NCH), 3.29-3.23 (m, 1H, NCH), 3.19-3.12 (m, 1H, NCH), 2.06-1.95 (m,
1H, CH), 1.82-1.72 (m, 3H, CH), 1.45 (s, 9H, CMe3), 0.04 (s, 9H,
SiMe3); 13C NMR (100.6 MHz, CDCl3) (rotamers)
d 154.6 (C]O), 79.2
(CMe3), 78.3 (CMe3), 47.6 (NCH), 47.0 (NCH2), 46.6 (NCH2), 28.5
(CMe3), 27.9 (CH2), 26.0 (CH2) 24.9 (CH2), ꢀ2.2 (SiMe3). Spectro-
scopic data consistent with those reported in the literature [26].
4.5. General procedure D: lithiation-trapping in 2-MeTHF or Et2O
with TMEDA followed by incubation
4.8. N-(tert-Butoxycarbonyl)pyrrolidine-2-carboxaldehyde 4
Using general procedure A, s-BuLi (1.0 mL of a 1.3 M solution in
s-BuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol) was
added dropwise to a stirred solution of N-Boc pyrrolidine 1 (171 mg,
hexanes, 1.3 mmol) and N-Boc pyrrolidine 1 (171 mg, 175
mL,
1.0 mmol) in 2-MeTHF (7 mL) at ꢀ20 ꢁC for 2 min and DMF (146 mg,
175 mL, 1.0 mmol) and TMEDA (151 mg, 195 mL, 1.3 mmol) in Et2O or
155
mL, 2.0 mmol) gave the crude product. Purification by flash
2-MeTHF (7 mL) at ꢀ30 ꢁC under Ar. The resulting solution was
stirred at ꢀ30 ꢁC for 5 min. The reaction flask was transferred to a
0 ꢁC bath and stirred at 0 ꢁC for 5 or 30 min. Then, Me3SiCl (218 mg,
column chromatography on silica with 1:1 hexane-Et2O as eluent
gave aldehyde 4 (105 mg, 52%) as a colourless oil, RF (1:1 hexane-
Et2O) 0.3; 1H NMR (400 MHz, CDCl3) (60:40 mixture of rotamers)
256 mL, 2.0 mmol) was added. The resulting solution was stirred at
d
9.56 (d, J ¼ 2.0 Hz, 0.4H, CHO), 9.46 (d, J ¼ 3.0 Hz, 0.6H, CHO), 4.24-
0 ꢁC for 10 min and then allowed to warm to rt over 1 h. Saturated
NH4Cl(aq) (10 mL) was added and the two layers were separated.
The aqueous layer was extracted with Et2O (3 ꢄ 10 mL) and the
combined organic layers were dried (MgSO4) and evaporated under
reduced pressure to give the crude product. Table 2.
4.17 (m, 0.4H, NCH), 4.05 (ddd, J ¼ 8.5, 6.0, 3.0 Hz, 0.6H, NCH), 3.61-
3.38 (m, 2H, NCH), 2.20-1.74 (m, 4H, CH), 1.48 (s, 4H, CMe3), 1.43 (s,
5H, CMe3); 13C NMR (100.6 MHz, CDCl3) (rotamers)
d 200.7 (C]O,
CHO), 200.5 (C]O, CHO), 154.0 (C]O, Boc), 80.6 (CMe3), 80.2
(CMe3), 65.0 (NCH), 64.8 (NCH), 46.8 (NCH2), 46.7 (NCH2), 28.4
(CMe3), 28.2 (CMe3), 28.0 (CH2), 26.7 (CH2) 24.6 (CH2), 23.9 (CH2).
Spectroscopic data consistent with those reported in the literature
4.6. 2-(Hydroxyphenylmethyl)pyrrolidine-1-carboxylic acid tert-
butyl ester syn-2 and anti-2
Using general procedure A, s-BuLi (1.0 mL of a 1.3 M solution in
4.9. General procedure E: continuous flow synthesis of 2-
hexanes, 1.3 mmol) and N-Boc pyrrolidine 1 (171 mg, 175
m
L,
trimethylsilyl pyrrolidine-1-carboxylic acid tert-butyl ester 2
1.0 mmol) in 2-MeTHF (7 mL) at ꢀ20 ꢁC for 2 min and benzaldehyde
(228 mg, 203
m
L, 2.0 mmol) gave the crude product. Purification by
A Uniqsis FlowSyn system fitted with a T-mixer and a 0.1 mL
reaction tube (0.5 mm ID ꢄ 50 cm PTFE tubing) was flushed with
anhydrous THF (100 mL) under N2 and the pre-mixer tubing, mixer
and reaction tubing was cooled to 0 ꢁC. The end of the reaction
flash column chromatography on silica with 98:2 CH2Cl2-acetone as
eluent gave pyrrolidine syn-2 (119 mg, 43%) as a colourless oil, RF
(98:2 CH2Cl2-acetone) 0.4; 1H NMR (400 MHz, CDCl3)
d 7.38-7.27
(m, 5H, Ph), 5.93 (br s, 1 H, OH), 4.53 (br d, J ¼ 7.5 Hz 1H, OCH), 4.09
(td, J ¼ 7.5, 5.0 Hz, 1H, NCH), 3.50-3.42 (m, 1H, NCH), 3.39-3.28 (m,
1H, NCH), 1.78-1.65 (m, 2H, CH), 1.65-1.56 (m, 2H, CH), 1.52 (s, 9H,
tubing was added to a 2-neck RBF containing Me3SiCl (761
6.0 mmol, 2.0 eq.) at 0 ꢁC under N2. A solution of N-Boc pyrrolidine
1 (526 L, 3.0 mmol, 1.0 eq., 0.20 M) and TMEDA (585 L, 3.9 mmol,
mL,
m
m
CMe3); 13C NMR (100.6 MHz, CDCl3)
d
158.5 (C]O), 141.3 (ipso-Ph),
1.3 eq., 0.26 M) in anhydrous THF (15 mL) under N2 was pumped
through the FlowSyn system at a flow rate between 0.5 and
1.67 mL minꢀ1. Simultaneously, s-BuLi (1.3 M solution in hexanes,
3.0 mL, 3.9 mmol,1.3 eq.) was pumped through the FlowSyn system
at a flow rate between 0.10 and 0.33 mL minꢀ1 from a 3 mL injection
loop placed after the peristaltic pump. After 9e30 min, the flow
reactor was stopped and the reaction was quenched with saturated
NH4Cl(aq) (10 mL). Et2O (20 mL) was added and the two layers were
separated. The aqueous layer was extracted with Et2O (2 ꢄ 20 mL)
and the combined organic extracts were dried (MgSO4) and evap-
orated under reduced pressure to give the crude product.
128.8 (Ph), 128.6 (Ph), 127.2 (Ph), 81.1 (OCH), 79.5 (CMe3), 65.5
(NCH), 47.9 (NCH2), 28.8 (CH2), 28.7 (CMe3), 24.0 (CH2), a 65:35
mixture (by 1H NMR spectroscopy) of pyrrolidine anti-2 and syn-2
(4 mg, 1%) as a colourless oil and pyrrolidine anti-2 (70 mg, 25%) as
a colourless oil, RF (98:2 CH2Cl2-acetone) 0.3; 1H NMR (400 MHz,
CDCl3) (75:25 mixture of rotamers) d 7.41-7.22 (m, 5H, Ph), 5.49 (br
s, 0.75H, OH), 5.17 (br s, 0.25H, OH), 4.86 (br s, 0.75H, OCH), 4.32 (br
s, 0.75H, NCH), 3.97 (br s, 0.25H, OCH), 3.57 (br s, 0.25H, NCH), 3.30
(br s, 1H, NCH), 2.81 (br s, 0.75H, NCH), 2.30 (br s, 0.25H, NCH),
2.04-1.87 (m, 1H, CH), 1.86-1.66 (m, 1H, CH), 1.57 (br s, 3.5 H, CMe3),
1.52 (br s, 5.5 H, CMe3), 1.20-1.09 (m, 1H, CH), 0.93-0.79 (m, 1H, CH);
13C NMR (100.6 MHz, CDCl3)
d
159.8 (C]O), 157.4 (C]O), 141.9
4.10. 2-Trimethylsilyl pyrrolidine-1-carboxylic acid tert-butyl ester
3
(ipso-Ph), 141.3 (ipso-Ph), 128.5 (Ph), 128.3 (Ph), 128.1 (Ph), 127.4
(Ph), 127.1 (Ph), 126.1 (Ph), 80.5 (CMe3), 80.4 (CMe3), 76.3 (COH),
63.3 (NCH), 47.9 (NCH2), 47.7 (NCH2), 28.6 (CMe3), 27.5 (CH2), 26.1
(CH2), 23.6 (CH2), 22.6 (CH2). Spectroscopic data consistent with
those reported in the literature [25]. The total yield of syn-2 and
Using general procedure E, N-Boc pyrrolidine 1 (526
3.0 mmol, 1.0 eq., 0.20 M) and TMEDA (585 L, 3.9 mmol, 1.3 eq.,
0.26 M) at 1.25 mL minꢀ1, s-BuLi (1.3 M solution in hexanes, 3.0 mL,
3.9 mmol, 1.3 eq.) at 0.25 mL minꢀ1 and Me3SiCl (761
L, 6.0 mmol,
mL,
m
m
5